BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at UBS
Tweet Send to a Friend
UBS analyst Eliana Merle raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $114.00 (from $113.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
